NEA Management Company’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
SL
NEA Management Company's ORIC Position: Q3 2026 in Review
NEA Management Company held its Oric Pharmaceuticals (ORIC) position steady in Q3 2026 at 4,118,621 shares worth $55.5M. The position accounts for 4.07% of the portfolio, ranked #11.
NEA Management Company first reported a position in ORIC in Q1 2024 and has held it in 11 quarters since. 202 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- NEA Management Company held 4,118,621 shares of Oric Pharmaceuticals worth $55.5M as of Q3 2026.
- NEA Management Company left its Oric Pharmaceuticals share count unchanged in Q3 2026.
- Oric Pharmaceuticals made up 4.07% of NEA Management Company's portfolio in Q3 2026, its #11 holding.
- NEA Management Company first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
- 202 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on NEA Management Company's 13F filing for Q3 2026, filed 16 Nov 2026.